Researchers are excited about the medication , a novel dual compound showing significant outcomes in clinical trials for size loss . It works by impacting both pathways : GLP-1 and GIP, which , when https://mariyahnofj328560.losblogos.com/39579063/a-new-prospect-for-weight-reduction